crystalline form of the compound (2r, 3s, 4r, 5s) -1-butyl-2- (hydroxymethyl) piperidine-3,4,5-triol, process for preparing the crystalline form of the compound, pharmaceutical composition, capsule, use of a crystalline form of the compound, a pharmaceutical composition or a capsule; and, method of treatment or prophylaxis of fabry disease.

摘要

the invention relates to a crystalline form of [(2r, 3s, 4r, 5s) -1-butyl-2- (hydroxymethyl) -piperidine-3,4,5-triol, processes for preparing the same, compositions pharmaceuticals containing such crystalline form and its use as a medicine, especially as an inhibitor of glycolipid biosynthesis.